May 11, 2020 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation First Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference to your speaker today, Pam Murphy. Please go ahead, ma'am.
Pam Murphy - Arbutus Biopharma Corporation - IR Consultant
Thank you, and good morning, everyone. On the call from the Arbutus executive team are Bill Collier, President and Chief Executive Officer; Dr. Michael Sofia, Chief Scientific Officer; Dave Hastings, Chief Financial Officer; and Dr. Gaston Picchio, Chief Development Officer. Bill will begin with a summary of recent accomplishments and a review of Arbutus' corporate objectives, followed by Dr. Sofia, who will then describe the recently announced Arbutus COVID-19 research effort. Dave Hastings will then provide a review of the company's first quarter financial results, and we'll then open up the call for Q&A.
Q1 2020 Arbutus Biopharma Corp Earnings Call Transcript
May 11, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers